NCT06350318
- Conditions
- B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Clinical trial condition
Marginal Zone Lymphoma
Explore clinical trials studying Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.
114 public trials
41 recruiting studies
Marginal Zone Lymphoma trial results
NCT04669171
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
- University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) Rochester, New York, United States
- University of Washington-Seattle Cancer Care Alliance Seattle, Washington, United States
NCT04792502
- Conditions
- B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Lifespan Cancer Insitute Providence, Rhode Island, United States
NCT05602363
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
- Locations
-
- UC Irvine Health Orange, California, United States
- Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern Memorial Hospital Chicago, Illinois, United States
NCT06390956
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Washington University St Louis, Missouri, United States
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
Recruiting
A Cohort Study in Newly Diagnosed MZL
NCT06449885
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Recruiting
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
NCT07233720
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Zhengzhou, Henan, China
NCT05643742
- Conditions
- B-cell Lymphoma, B-cell Malignancy, Chronic Disease, +27 more
- Locations
-
- University of Kansas Westwood, Kansas, United States
- Washington University St Louis, Missouri, United States
- SCRI San Antonio, Texas, United States
- University of Utah Salt Lake City, Utah, United States
Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
NCT03452774
- Conditions
- Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
- Locations
-
- Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
- Massive Bio SYNERGY-AI site Mobile, Alabama, United States
- Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
- Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
NCT06796998
- Conditions
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- University of Miami Miami, Florida, United States